Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up.

MLA

Sok, Caitlin P., et al. “Molecular Pathology and Protein Markers for Pancreatic Cancer: Relevance in Staging, in Adjuvant Therapy, in Determination of Minimal Residual Disease, and Follow-Up.” Hepatobiliary Surgery and Nutrition, vol. 13, no. 1, Feb. 2024, pp. 56–70. EBSCOhost, https://doi.org/10.21037/hbsn-22-628.

APA

Sok, C. P., Polireddy, K., & Kooby, D. A. (2024). Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up. Hepatobiliary Surgery and Nutrition, 13(1), 56–70. https://doi.org/10.21037/hbsn-22-628

Chicago

Sok, Caitlin P, Karunesh Polireddy, and David A Kooby. 2024. “Molecular Pathology and Protein Markers for Pancreatic Cancer: Relevance in Staging, in Adjuvant Therapy, in Determination of Minimal Residual Disease, and Follow-Up.” Hepatobiliary Surgery and Nutrition 13 (1): 56–70. doi:10.21037/hbsn-22-628.